Ziyuanyuan Holdings Group Limited (HKG:8223)
0.6500
-0.0500 (-7.14%)
Feb 13, 2026, 4:08 PM HKT
Ziyuanyuan Holdings Group Revenue
Ziyuanyuan Holdings Group had revenue of 207.11M CNY in the half year ending June 30, 2025, with 24.52% growth. This brings the company's revenue in the last twelve months to 525.30M, up 6.60% year-over-year. In the year 2024, Ziyuanyuan Holdings Group had annual revenue of 498.71M with 4.21% growth.
Revenue (ttm)
525.30M CNY
Revenue Growth
+6.60%
P/S Ratio
0.49
Revenue / Employee
11.94M CNY
Employees
44
Market Cap
279.50M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 498.71M | 20.13M | 4.21% |
| Dec 31, 2023 | 478.57M | 173.20M | 56.72% |
| Dec 31, 2022 | 305.37M | 196.11M | 179.49% |
| Dec 31, 2021 | 109.26M | 60.48M | 123.97% |
| Dec 31, 2020 | 48.78M | -4.88M | -9.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 626.85B |
| Charmacy Pharmaceutical | 4.65B |
| Sipai Health Technology | 3.75B |
| ETHK Labs | 3.37B |
| Sinco Pharmaceuticals Holdings | 2.73B |
| ClouDr Group | 2.47B |
| 160 Health International | 698.59M |
| Wanjia Group Holdings | 163.70M |